Skip to content
★ Sign in to follow
Hester Biosciences Limited logo

Hester Biosciences Limited Stock: price and insider trades · India

IN·Mcap ₹21.1BHealth Care

No insider purchase over the last 90 days. The latest, by RAJIV DINESH GANDHI, was filed 05 Sept 2025.

Hester Biosciences Limited: what insiders have been doing

Every trade that managers of Hester Biosciences Limited disclose to SEBI (PIT + SAST) is tracked on this page. The company sits in the Health Care sector. Hester Biosciences Limited has had no insider filing for more than a year; the last one goes back to 5 September 2025.

In the same sector, recent insider purchases at Relmada Therapeutics, Inc. and MAIA Biotechnology, Inc. also feature in our signals. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.

Insider Decl.
4
Thresholds
n/a
Buy Volume
n/a
2 ops. · all time
Sell Volume
n/a
2 ops. · all time

Who traded when

BuySale
Bhupendra Vithaldas Gandhi1 sale
Rajiv Dinesh Gandhi1 buy
Fundamental score
Ranked 9,843 of 26,912 companies
58.2
score / 100
Value
41
Quality
76
FCF yld2.4%
Earn yld2.9%
EV/EBITDA20.8x
ROE17%
Gross mgn72%
Net mgn17%
Debt/EBITDA1.9x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended March 2026 · cache

₹2,477.70
Analyst consensus
·
Income statement
Revenue₹3.3B
Gross profit₹2.4B72% margin
EBITDA₹1B31% margin
Net income₹556.4M41.7% margin
Valuation
PER (trailing)15.6x
P/Book5.9x
Beta0.49
Balance sheet & cash
Market cap₹21.1B
Total debt₹1.9B
Free Cash Flow₹463.1M
Debt / Equity53%
Profitability & ownership
ROE16.6%
ROA6.5%
% insiders68.8%
% institutions0.3%
Last declaration on 5 September 2025
Declarations4 total
  • ▲
    Executives
    0SEBI
    1,111 sharesEquity SharesSEBI:395a45d3f60ce9f4714270d41f6be4525ea2307d
    Canonical exit: 3 Dec 2025 (T+90)
  • ▼
    Executives
    0SEBI
    1,111 sharesEquity SharesSEBI:9b201c27a6b2ec869f66b10959b6471dffee79f3
  • ▲
    Executives
    0SEBI
    301,600 sharesEquity SharesSEBI:020694f8e0a54a1668dab38bdda6acbc4778c524
    Canonical exit: 7 May 2023 (T+90)
  • ▼
    Related company / holdingExecutives
    0SEBI
    301,600 sharesEquity SharesSEBI:deaf7eee8b239e49e8038570fd7cbc0544c95453

4 of 4 declarations

About Hester Biosciences Limited

Hester Biosciences Limited is a company focused on health and pharmaceuticals, specializing in the production of vaccines and biological products. It is listed on the XBOM market.